Infants born to women who were treated with antibodies against tumor necrosis factor alpha (TNF alpha) during pregnancy have detectable levels of antibodies until 12 months of age, according to the results of a recent study published in the journal Gastroenterology.
In this Mayo Clinic video, learn more about the increased risk for adverse birth outcomes in women with inflammatory bowel disease (IBD) with Dr. Sunanda Kane, M.D.
Learn more about IBD here: http://bit.ly/learnIBD
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?